Ototoxicity: Mechanisms, protective agents, and monitoring

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 8, Issue 5, 2000, Pages 436-440

  Campbell, Kathleen C M ^a   Kalkanis, James ^a   Glatz, F Robert ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 METHYLTHIOBENZOIC ACID; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; BENZOIC ACID DERIVATIVE; CISPLATIN; DEXTRO METHIONINE; DIETHYLDITHIOCARBAMIC ACID; DIZOCILPINE; DOXORUBICIN; EBSELEN; EPIDERMAL GROWTH FACTOR; ETACRYNIC ACID; GENTAMICIN; INDUSTRIAL CHEMICAL; INSULIN; ION CHANNEL; IRON CHELATE; KANAMYCIN; METAL CHELATE; METHIONINE DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID; NEUROTROPHIN 3; RETINOIC ACID; SALICYLIC ACID DERIVATIVE; THIOCTIC ACID; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINBLASTINE SULFATE; VINCRISTINE SULFATE;

AREA UNDER THE CURVE; AUDIOLOGY; AUDIOMETRY; BRAIN STEM RESPONSE; CORTI ORGAN; DIAGNOSTIC PROCEDURE; DRUG BLOOD LEVEL; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HUMAN; LIPID PEROXIDATION; MEDICAL LITERATURE; MEDICAL RESEARCH; NONHUMAN; OTOACOUSTIC EMISSION; OTOTOXICITY; OXIDATIVE STRESS; PATIENT MONITORING; PERILYMPH; PRIORITY JOURNAL; REVIEW; STRIA VASCULARIS; TOXICOKINETICS; TREATMENT OUTCOME;

EID: 0034453767     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/00020840-200010000-00015     Document Type: Review

References (24)

1. Aminoglycoside antibiotics
2. Once-daily gentamicin dosing in newborn infants
3. Toxicity of single daily dose gentamicin in stem cell transplantation
4. An individualized, sensitive frequency range for early detection of ototoxicity
5. Hair cell protection from aminoglycoside ototoxicity by adenovirus-mediated overexpression of glial cell line-derived neurotrophic factor
6. Effects of BDNF and NT-3 on hair cell survival in guinea pig cochlea damaged by kanamycin treatment
7. The protective effect of brain-derived neurotrophic factor after gentamicin ototoxicity
8. 4-Methylcatechol, a potent inducer of nerve growth factor synthesis, protects spiral ganglion neurons from aminoglycoside ototoxicity: Preliminary report
9. Effects of growth factors on the hair cells after ototoxic treatment of the neonatal mammalian cochlea in vitro
10. Dizocilpine attenuates streptomycin-induced vestibulotoxicity in rats
11. Polyamine-like actions of aminoglycosides at recombinant N-methyl-D-aspartate receptors
12. Salicylate attenuates gentamicin-induced ototoxicity
13. The A1555G mutation in the 12S rRNA gene of human mtDNA: Recurrent origins and founder events in families affected by sensorineural deafness
14. Inherited susceptibility to aminoglycoside ototoxicity: Genetic heterogeneity and clinical implications
15. The electroreceptor organ of the catfish, Ictalurus melas, as a model for cisplatin-induced ototoxicity
16. Satu: Application of antioxidants and other agents to prevent cisplatin ototoxicity
17. Cisplatin-induced hearing loss: Influence of the mode of drug administration in the guinea pig
18. D-Methionine protects against cisplatin damage to the stria vascularis
19. Ototoxicity associated with vinblastine
20. Cisplatin ototoxicity
21. ABR evaluation of ototoxicity in cancer patients receiving cisplatin or carboplatin
22. Evaluation of organic solvent ototoxicity by the upper limit of hearing
23. Effects of chronic tobramycin treatment on distortion product otoacoustic emissions
24. Otoacoustic emissions: An approach for monitoring aminoglycoside induced ototoxicity in children